{{Rsnum
|rsid=7732320
|Gene=SSBP2
|Chromosome=5
|position=81423306
|Orientation=plus
|GMAF=0.1956
|Gene_s=SSBP2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 79.6 | 17.7 | 2.7
| HCB | 88.1 | 10.4 | 1.5
| JPT | 85.6 | 13.5 | 0.9
| YRI | 30.1 | 37.7 | 32.2
| ASW | 29.8 | 54.4 | 15.8
| CHB | 88.1 | 10.4 | 1.5
| CHD | 87.0 | 13.0 | 0.0
| GIH | 83.0 | 15.0 | 2.0
| LWK | 27.5 | 47.7 | 24.8
| MEX | 74.1 | 20.7 | 5.2
| MKK | 36.8 | 45.8 | 17.4
| TSI | 84.0 | 15.0 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22472174
|Trait=None
|Title=SSBP2 Variants Are Associated with Survival in Glioblastoma Patients.
|RiskAllele=T
|Pval=0.000001
|OR=1.6400
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}